Personalising docetaxel and G-CSF schedules in cancer patients by a clinically validated computational model

BACKGROUND: This study was aimed to develop a new method for personalising chemotherapeutic and granulocyte colony-stimulating factor (G-CSF) combined schedules, and use it for suggesting efficacious chemotherapy with reduced neutropenia. METHODS: Clinical data from 38 docetaxel (Doc)-treated metast...

Descripción completa

Detalles Bibliográficos
Autores principales: Vainas, O, Ariad, S, Amir, O, Mermershtain, W, Vainstein, V, Kleiman, M, Inbar, O, Ben-Av, R, Mukherjee, A, Chan, S, Agur, Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425973/
https://www.ncbi.nlm.nih.gov/pubmed/22814580
http://dx.doi.org/10.1038/bjc.2012.316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425973/
https://www.ncbi.nlm.nih.gov/pubmed/22814580
http://dx.doi.org/10.1038/bjc.2012.316

Ejemplares similares